Femeda
Generated by Meeveem AI
"Pioneering clinical solutions for women's pelvic health and urinary incontinence treatment"
Cramlington
•11 - 50 Employees
•Medical Devices
About Femeda
Femeda develops medical devices addressing urinary incontinence, affecting one in three women globally. Its flagship product, Pelviva, is a clinically proven pelvic floor retrainer using neuromuscular electrical stimulation and microprocessor technology. The single use device delivers measurable results, with 84 percent of users reporting improved bladder control after 12 weeks. Femeda bridges clinical research and consumer healthcare, transforming outcomes for women with limited options. Through partnerships with universities, the NHS, and healthcare providers, the company brings evidence based innovation to a market valued at over 13 billion pounds, empowering women to reclaim confidence and quality of life.
14
Team Members
2002
Founded
Medical Devices
Sector
On-Site
Work Environment
Our Vision
A world where every woman has access to effective, dignified solutions for pelvic health, free from embarrassment and constraint, living with complete confidence and physical freedom in all aspects of life.
Our Mission
Femeda exists to transform the lives of women experiencing urinary incontinence by developing clinically proven, accessible medical devices that restore bladder control and deliver measurable improvements in quality of life.